Rafferty Asset Management’s IDEAYA Biosciences IDYA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.89M	Sell	86,684 -39,678	-31%	-$1.33M	0.01%	522
2025 Q4	$4.37M	Buy	126,362 +33,210	+36%	+$1.06M	0.02%	466
2025 Q3	$2.53M	Sell	93,152 -16,655	-15%	-$403K	0.01%	589
2025 Q2	$2.31M	Sell	109,807 -11,581	-10%	-$222K	0.01%	569
2025 Q1	$1.99M	Buy	121,388 +3,161	+3%	+$67.3K	0.01%	581
2024 Q4	$3.04M	Sell	118,227 -7,792	-6%	-$221K	0.01%	520
2024 Q3	$3.99M	Sell	126,019 -5,077	-4%	-$193K	0.01%	468
2024 Q2	$4.6M	Sell	131,096 -70,195	-35%	-$2.78M	0.02%	438
2024 Q1	$8.83M	Buy	201,291 +7,935	+4%	+$341K	0.03%	315
2023 Q4	$6.88M	Buy	193,356 +64,280	+50%	+$1.92M	0.03%	375
2023 Q3	$3.48M	Buy	129,076 +4,059	+3%	+$103K	0.02%	473
2023 Q2	$2.94M	Sell	125,017 -2,616	-2%	-$53.8K	0.02%	534
2023 Q1	$1.75M	Sell	127,633 -26,630	-17%	-$444K	0.01%	648
2022 Q4	$2.8M	Buy	154,263 +42,144	+38%	+$709K	0.02%	499
2022 Q3	$1.67M	Buy	112,119 +67,952	+154%	+$883K	0.02%	551
2022 Q2	$610K	Sell	44,167 -64,772	-59%	-$720K	0.01%	769
2022 Q1	$1.22M	Buy	108,939 +2,234	+2%	+$32.9K	0.01%	738
2021 Q4	$2.52M	Buy	106,705 +75,230	+239%	+$1.75M	0.01%	583
2021 Q3	$802K	Buy	+31,475	New	+$735K	0.01%	924